Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-23
DOI
10.1038/s41598-017-04706-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
- (2016) Pauline Vercruysse et al. BRAIN
- Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis
- (2016) Lucas T. Vu et al. Neurotherapeutics
- Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
- (2016) Bram. P. Prins et al. PLOS MEDICINE
- Association between diabetes and amyotrophic lateral sclerosis in Sweden
- (2015) D. Mariosa et al. EUROPEAN JOURNAL OF NEUROLOGY
- Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
- (2015) Sabrina Paganoni et al. MUSCLE & NERVE
- Obesity, adipokines and neuroinflammation
- (2015) Argel Aguilar-Valles et al. NEUROPHARMACOLOGY
- Adipokines in health and disease
- (2015) Mathias Fasshauer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis
- (2015) Marianthi-Anna Kioumourtzoglou et al. JAMA Neurology
- Epidemiological evidence that physical activity is not a risk factor for ALS
- (2014) Bello Hamidou et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis
- (2014) Maria A. Lim et al. HUMAN MOLECULAR GENETICS
- Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) Anne-Marie Wills et al. LANCET
- Neurobiology of food intake in health and disease
- (2014) Gregory J. Morton et al. NATURE REVIEWS NEUROSCIENCE
- Neuroprotective effects of leptin in the context of obesity and metabolic disorders
- (2014) Cecilia Davis et al. NEUROBIOLOGY OF DISEASE
- Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia
- (2014) Hatice Uenal et al. PLoS One
- Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics
- (2014) Kay A. Lawton et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia
- (2013) Gabriele Nagel et al. BMC Neurology
- Lifetime physical activity and the risk of amyotrophic lateral sclerosis
- (2013) M. H. B. Huisman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort
- (2013) V. Gallo et al. NEUROLOGY
- Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
- (2013) Eva Lindauer et al. PLoS One
- Amyotrophic lateral sclerosis
- (2012) Albert C. Ludolph et al. CURRENT OPINION IN NEUROLOGY
- Premorbid body mass index and risk of amyotrophic lateral sclerosis
- (2012) Éilis J. O'Reilly et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis
- (2011) N. A. Sutedja et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study: Table 1
- (2011) Martin R Turner et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
- (2011) Sabrina Paganoni et al. MUSCLE & NERVE
- A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS
- (2010) Ali Jawaid et al. Amyotrophic Lateral Sclerosis
- ALS disease onset may occur later in patients with pre-morbid diabetes mellitus
- (2010) A. Jawaid et al. EUROPEAN JOURNAL OF NEUROLOGY
- Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis
- (2010) J. Dorst et al. JOURNAL OF NEUROLOGY
- Energy metabolism in amyotrophic lateral sclerosis
- (2010) Luc Dupuis et al. LANCET NEUROLOGY
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
- (2008) L. Dupuis et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now